Abeona Therapeutics Inc

:ABEO 4:00:00 PM EDT

4.96

-0.06 (-1.10%)

5:52:39 PM EDT: $4.92 -0.04 (-0.71%)

Market Cap (Intraday)	268.51M
Current PE	N/A
Forward PE	4.31
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.42 Million
Adjusted EPS	-$0.35

See more estimates

10-Day MA	$5.04
50-Day MA	$5.14
200-Day MA	$5.62

See more pivots

Abeona Therapeutics Inc Stock, :ABEO

6555 Carnegie Avenue, 4th floor, Cleveland, Ohio 44103

United States of America

Phone: +1.646.813.4701

Number of Employees: 84

http://www.abeonatherapeutics.com

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.